-
In the Pipeline
-
FDA approves generic omeprazole; Study says schools often stray from set guidelines; Warnings strengthened by urokinase reintroduction; Complications related to bone cement, FDA says; In the year 2020: Shortfall of even more pharmacists.
-
New FDA Approvals
-
Neuroleptic malignant syndrome (NMS) is a rare but life-threatening adverse effect that is associated with neuroleptic drugs, primarily the phenothiazines. NMS has occurred with even the less potent phenothiazines that are used to treat nausea, such as promethazine.
-
-
Hispanic population growth is a trend hospice must embrace, but it wont be easy, experts say.
-
Anyone with doubts about the commitment of todays teen-agers need look only to the state of Florida. There, more than 200 teenage hospice volunteers are shattering any negative images of their generation by providing direct hospice patient care in homes, nursing homes, inpatient hospice, and assisted living facilities.
-
The University of Maryland Medical Center is helping to blur the line between curative care and palliative care. Taking a page out of hospices book by implementing an interdisciplinary team, staff are able to provide both palliative care and life-saving care at the same time regardless of whether the patient is terminally ill.
-
Overall home care industry revenue growth in 2001 was 10%, a decrease of 3% from the revenue growth experienced in 2000, according to results of the 2002 Financial Performance Survey Report, an annual benchmarking survey of financial and management practices conducted by the Alexandria, VA-based American Association for Homecare.
-
